Xiaoran Han

Dr. Han has over 10 years of experience in studying the function and mechanism of the ubiquitin-proteasome pathway in cancer development and drug discovery, particularly in cullin-RING family E3 ligase (CRLs) and degrader discovery. She received a Bachelor of Science degree in biology from Ocean University of China in 2010 and a doctorate in biochemistry and molecular cell biology from Fudan University in 2015. After completing postdoctoral training at University of North Carolina at Chapel Hill, Dr. Han joined Cullgen upon its inception in 2018. To date, Dr. Han has co-authored over 10 peer-reviewed research publications and been an inventor of more than 15 issued or published international patent applications.